Coca-Cola has struggled to integrate its $5.6 billion purchase of BodyArmor with Powerade, which led to more “disruption in the short-term” than expected, according to CEO James Quincey.
Body Armor’s sales declined in the latest quarter.
The Atlanta-based Coca-Cola is optimistic that BodyArmor will eventually complement Powerade, its other big offering in the sports-drink category, as it aims to better compete against industry heavyweight, Pepsi-owned Gatorade.
BodyArmor’s purchase is the largest acquisition in Coca-Cola’s history.
In 2018, Coca-Cola first paid an undisclosed sum for a 15% share in BodyArmor, which had revenues of around $250 million.
That amount increased to more than $1 billion in 2021 when it acquired the remaining shares of brand to increase the variety of beverages it offers.
Through the use of coconut water, low sodium and high potassium levels, the lack of artificial colors, and the addition of sugar in place of high fructose corn syrup, the fast-growing, healthier sports drink gained popularity among consumers.
The purchase of BodyArmor by Coca-Cola led to a big bet that the beverage would play a key role in building out its liquid offerings and repositioning the business into a “total beverage company.”
Coca-Cola’s U.S. sports-drink market share had slipped in recent months. Still, the Coke chief remains optimistic this year will be a turning point for BodyArmor.


Gold, Silver, and Platinum Rally as Precious Metals Recover from Sharp Selloff
Trump’s U.S. Open Visit Delays Final, Fans Face Long Security Lines
U.S. Plans $115 Million Counter-Drone Investment to Secure FIFA World Cup and Major National Events
S&P 500 Rises as AI Stocks and Small Caps Rally on Strong Earnings Outlook
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
Japan’s Agricultural, Forestry and Fishery Exports Hit Record High in 2025 Despite Tariffs
Why Manchester City offered Erling Haaland the longest contract in Premier League history
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Taiwan Urges Stronger Trade Ties With Fellow Democracies, Rejects Economic Dependence on China
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Trump Signs Executive Order Targeting Big-Money College Athlete Payouts
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers 



